{"DataElement":{"publicId":"7247379","version":"1","preferredName":"Immunotherapeutic Agent Related Adverse Event Hematologic and Lymphocytic Disorder Present Type","preferredDefinition":"Information related to the type of hematologic and lymphocytic disorder immunotherapeutic related adverse event that is present.","longName":"7247378v1.0:7247368v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"7247378","version":"1","preferredName":"Immunotherapeutic Agent Relationship Adverse Event Hematologic and Lymphocytic Disorder Present","preferredDefinition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system._A state of connectedness between people, objects, or events; to be associated or connected with something._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation._Being or existing in a specified place or at the specified time.","longName":"6955286v1.0:7247376v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"6955286","version":"1","preferredName":"Immunotherapeutic Agent Relationship Adverse Event","preferredDefinition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.:A state of connectedness between people, objects, or events; to be associated or connected with something.:Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","longName":"C308:C25648:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EC8B94-DB7D-03ED-E053-F662850AFC99","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7247376","version":"1","preferredName":"Hematologic and Lymphocytic Disorder Present","preferredDefinition":"A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.:Being or existing in a specified place or at the specified time.","longName":"C26323:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36C8230-6437-6D9D-E053-F662850AB561","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36C8230-6448-6D9D-E053-F662850AB561","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"MORENOC","dateModified":"2020-07-01","changeDescription":"7/1/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7247368","version":"1","preferredName":"Immunotherapeutic Related Adverse Event Hematologic and Lymphocytic Disorder Type","preferredDefinition":"The type of hematologic and lymphocytic disorder immunotherapeutic related adverse event.","longName":"7247368v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B11-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Hemolytic anemia","valueDescription":"Hemolytic Anemia","ValueMeaning":{"publicId":"2579904","version":"1","preferredName":"Hemolytic Anemia","longName":"2579904","preferredDefinition":"Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemolytic Anemia","conceptCode":"C34376","definition":"Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-052D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B1B-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Leukopenia","valueDescription":"Leukopenia","ValueMeaning":{"publicId":"2943829","version":"1","preferredName":"Leukopenia","longName":"2943829","preferredDefinition":"A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukopenia","conceptCode":"C26816","definition":"A laboratory test result indicating a decreased number of white blood cells in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7428BBDA-1E55-B2E3-E040-BB89AD4317E1","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B2F-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":"Neutropenia","ValueMeaning":{"publicId":"4291757","version":"1","preferredName":"Neutropenia","longName":"4291757","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-63D5-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B39-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Bicytopenia","valueDescription":"Bi-Cytopenia","ValueMeaning":{"publicId":"7247370","version":"1","preferredName":"Bi-Cytopenia","longName":"7247370","preferredDefinition":"A deficiency of two of the three blood cell lineages; erythrocytes, leukocytes and platelets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bi-Cytopenia","conceptCode":"C36227","definition":"A deficiency of two of the three blood cell lineages; erythrocytes, leukocytes and platelets.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36C8E68-3B46-25BB-E053-F662850A5571","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B5F-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Pancytopenia","valueDescription":"Pancytopenia","ValueMeaning":{"publicId":"7247371","version":"1","preferredName":"Pancytopenia","longName":"7247371","preferredDefinition":"A finding of low numbers of red and white blood cells and platelets in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancytopenia","conceptCode":"C34889","definition":"A finding of low numbers of red and white blood cells and platelets in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36C8E68-3B6B-25BB-E053-F662850A5571","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B84-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Aplastic anemia","valueDescription":"Aplastic Anemia","ValueMeaning":{"publicId":"2593270","version":"1","preferredName":"Aplastic Anemia","longName":"2593270","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880D74E-659D-0A0D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3B8E-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Pure red cell aplasia","valueDescription":"Pure Red Cell Aplasia","ValueMeaning":{"publicId":"2593269","version":"1","preferredName":"Pure Red Cell Aplasia","longName":"2593269","preferredDefinition":"Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pure Red Cell Aplasia","conceptCode":"C34974","definition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia, and selective erythroid hypoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CD28-DF45-07EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3BA2-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Other hematological condition","valueDescription":"Other Hematologic and Lymphocytic Disorder","ValueMeaning":{"publicId":"6156458","version":"1","preferredName":"Other Hematologic and Lymphocytic Disorder","longName":"6156458","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematopoietic and Lymphoid Cell Disorder","conceptCode":"C26323","definition":"A non-neoplastic or neoplastic disorder that arises from the hematopoietic and lymphoid cells. Representative examples include disorders that affect the synthesis of hemoglobin, coagulation disorders, leukemias, and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A4C0CD-D002-142E-E053-F662850AC3EC","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A36C8E68-3BB6-25BB-E053-F662850A5571","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36C8E68-3AFA-25BB-E053-F662850A5571","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"MORENOC","dateModified":"2020-07-01","changeDescription":"7/1/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Specify Hematologic irAE","type":"Preferred Question Text","description":"Specify Hematologic irAE","url":null,"context":"Alliance"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Specify irAE","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36DAA52-56BB-272F-E053-F662850AE1EF","latestVersionIndicator":"Yes","beginDate":"2020-04-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-16","modifiedBy":"MORENOC","dateModified":"2020-11-19","changeDescription":"7/1/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}